Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Switching chemo on and off to reduce side effects March 13, 2018 A new anti-cancer drug that could be switched ‘on’ and ‘off’ inside the body has…
Breast Cancer Blood test could quickly predict if the drug palbociclib will help breast cancer patients March 2, 2018 A new study has found a blood test for cancer DNA could predict if a…
Cancer Drug News Light-activated cancer drugs without toxic side effects February 21, 2018 Future cancer drugs that are activated by light and don’t cause the toxic side-effects of…
Breast Cancer New international practice guidelines for tamoxifen treatment based on CYP2D6 genotype February 8, 2018 An international group of clinicians and scientists representing the Clinical Pharmacogenetics Implementation Consortium (CPIC) published…
Cancer Drug News Why basal cell tumours return when drug treatment stops February 7, 2018 What happens when the most common and least threatening type of cancer gets complicated? A…
Cancer Drug News 30 year treatment drought breaks for most common form of bladder cancer January 26, 2018 The Therapeutic Goods Administration has approved pembrolizumab (KEYTRUDA 200mg, every three weeks) as monotherapy for…
Cancer Drug News Cancer immunotherapy may work better in patients with specific genes December 23, 2017 Cancer cells arise when DNA is mutated, and these cells should be recognised as “foreign”…
Commentary We don’t need to change how we subsidise ‘breakthrough’ cancer treatments November 28, 2017 Richard De Abreu Lourenco, University of Technology Sydney; Marion Haas, University of Technology Sydney, and…
Cancer Drug News Experimental drug trial seeks to improve treatment for head and neck cancer November 24, 2017 A trial to test an experimental drug in patients with head and neck cancer launches…
Cancer Drug News COSA 2017: Do new drugs require new models of funding? November 15, 2017 Attendees at the Clinical Oncology Society of Australia Annual Scientific Meeting discussed whether new immunotherapy…